SHORT MINI-FUTURE - ZOETIS | Market Closed - Deutsche Boerse AG 01:50:45 2024-05-10 pm EDT | ||
| 4.64 EUR | -2.93% |
|
| Current month | -16.09% | ||
| 1 month | -10.42% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ZOETIS INC.
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 4.64 | -2.93% | 0 |
| 24-05-09 | 4.78 | -7.00% | 0 |
| 24-05-08 | 5.14 | +15.51% | 0 |
| 24-05-07 | 4.45 | -11.00% | 0 |
| 24-05-06 | 5 | +6.61% | 0 |
Delayed Quote Deutsche Boerse AG
Last update May 10, 2024 at 01:50 pm EDT
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | ZOETIS INC. |
| Issuer | 
Vontobel
|
| WKN | VM63SL |
| ISIN | DE000VM63SL3 |
| Date issued | 2023-12-15 |
| Strike | 218.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.69 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 6.8 € |
|---|---|
| Lowest since issue | 1.73 € |
Company Profile
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows:
- pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%);
- livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%);
- other (1.1%).
Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%).
At the end of 2022, the group has 29 production sites worldwide.
The United States accounts for 53.4% of net sales.
Sector
-
Consensus: Zoetis Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
169
USD
Average target price
211
USD
Spread / Average Target
+24.82%
- Stock Market
- Certificates
- Certificat